Seminar at University of Bergen
Explore AVITI24 with direct, in sample sequencing
Discover how you can explore biology at unprecedented depth with Element and the AVITI24™ 5D multiomics system. One integrated solution, AVITI24 seamlessly integrates single-cell, spatial co-detection of RNA, protein, and morphology, and next-gen sequencing—all powered by our innovative avidite base chemistry (ABC). With just a single platform, you can unlock Direct In Sample Sequencing without library prep and access flexible, high-quality, affordable NGS workflows. Join us to learn how AVITI24 can accelerate your next discovery.
Wednesday, September 24
Time: 10:00 - 11:30am
Location: Universitetet i Bergen, Klinisk institutt 2, Laboratoriebygget, Room 8.1/8.2, 8th floor, Jonas Lies vei 91B, 5021 Bergen
Title: Integrated Sequencing and Direct, In Sample Multiomics with AVITI24
Speaker:
 |
Wilfred van IJcken, PhD Senior Technical Sales Specialist Element Biosciences |
Wilfred van IJcken is Senior Technical Sales Specialist at Element Biosciences, with expertise in genomics, sequencing, and cell biology. He previously led the Genomics Core Facility at Erasmus University Medical Center in Rotterdam for over 20 years and co-founded Methylomics B.V., a startup developing methylation-based cancer biomarker technologies. Wilfred holds a PhD in Virology from Wageningen University and has published nearly 300 scientific papers.
Title: Decoding Cancer Complexity: High-Resolution Multiomic Profiling Using AVITI24
Speaker:
 |
Leonardo A. Meza-Zepeda, Dr philos Head Department of Core Facilities, and Head of Translational Genomics Project group at the Institute for Cancer Research Oslo University Hospital |
Leonardo A. Meza-Zepeda is a leading expert in genomics, advanced sequencing technologies, and cancer biology. As Head of the Genomics Core Facility at the Institute for Cancer Research, he leads the NorSeq-Cancer node—a specialised node of Norway’s national infrastructure for high-throughput sequencing. Meza-Zepeda has played a pivotal role in introducing and establishing novel platforms to study cancer genome structure and dynamics, and pioneered the adoption of Element Biosciences' AVITI24 system in Norway.